Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan H Gradman

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|February 6, 2016
SPRINT: To Whom Do the Results Apply?Alan H Gradman
Drugs & Aging|September 5, 2009
Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 yearsAlan H Gradman
Journal of the American College of Cardiology|August 23, 2014
Optimal blood pressure targets in older adults: how low is low enough?Alan H Gradman
Current Hypertension Reports|April 3, 2015
LCZ696: the next step in improving RAS inhibition?Alan H Gradman
Current Hypertension Reports|February 11, 2011
Renal nerve ablation for resistant hypertensionAlan H Gradman
Preventive Cardiology|July 10, 2007
Treating patients for cardiovascular protection: combination therapy to achieve complete renin-angiotensin system blockadeAlan H Gradman
Journal of Clinical Hypertension (Greenwich, Conn.)|November 9, 2010
Rationale for triple-combination therapy for management of high blood pressureAlan H Gradman
American Heart Journal|May 20, 2009
Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic interventionAlan H Gradman
Lancet (London, England)|February 14, 2017
A quarter-dose quadpill for initial treatment of hypertensionAlan H Gradman
Journal of Clinical Hypertension (Greenwich, Conn.)|September 15, 2004
Managing high-risk patients with hypertension: focus on the renin-angiotensin systemAlan H Gradman
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|February 6, 2016
SPRINT: To Whom Do the Results Apply?Alan H Gradman
Drugs & Aging|September 5, 2009
Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 yearsAlan H Gradman
Journal of the American College of Cardiology|August 23, 2014
Optimal blood pressure targets in older adults: how low is low enough?Alan H Gradman
Current Hypertension Reports|April 3, 2015
LCZ696: the next step in improving RAS inhibition?Alan H Gradman
Current Hypertension Reports|February 11, 2011
Renal nerve ablation for resistant hypertensionAlan H Gradman
Preventive Cardiology|July 10, 2007
Treating patients for cardiovascular protection: combination therapy to achieve complete renin-angiotensin system blockadeAlan H Gradman
Journal of Clinical Hypertension (Greenwich, Conn.)|November 9, 2010
Rationale for triple-combination therapy for management of high blood pressureAlan H Gradman
American Heart Journal|May 20, 2009
Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic interventionAlan H Gradman
Lancet (London, England)|February 14, 2017
A quarter-dose quadpill for initial treatment of hypertensionAlan H Gradman
Journal of Clinical Hypertension (Greenwich, Conn.)|September 15, 2004
Managing high-risk patients with hypertension: focus on the renin-angiotensin systemAlan H Gradman
Pageof 5